Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,513 | 248 | 68.9% |
| Travel and Lodging | $3,763 | 13 | 22.5% |
| Consulting Fee | $1,313 | 2 | 7.9% |
| Grant | $123.35 | 1 | 0.7% |
| Education | $6.97 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,029 | 36 | $0 (2021) |
| Medtronic Vascular, Inc. | $2,915 | 31 | $0 (2019) |
| Edwards Lifesciences Corporation | $1,573 | 12 | $0 (2023) |
| Amgen Inc. | $1,367 | 39 | $0 (2024) |
| ABIOMED | $1,305 | 10 | $0 (2023) |
| Medtronic, Inc. | $954.48 | 12 | $0 (2024) |
| Boston Scientific Corporation | $655.22 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $374.05 | 10 | $0 (2024) |
| Braemar Manufacturing, LLC | $287.08 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $285.93 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,202 | 41 | Medtronic, Inc. ($290.11) |
| 2023 | $1,152 | 31 | Medtronic, Inc. ($366.58) |
| 2022 | $837.23 | 20 | Medtronic, Inc. ($297.79) |
| 2021 | $1,217 | 13 | Abbott Laboratories ($447.57) |
| 2020 | $2,077 | 21 | Abbott Laboratories ($1,391) |
| 2019 | $3,092 | 44 | Abbott Laboratories ($1,694) |
| 2018 | $4,699 | 55 | Medtronic Vascular, Inc. ($2,073) |
| 2017 | $2,444 | 40 | Edwards Lifesciences Corporation ($1,159) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $138.30 | General |
| Category: AVVIGO_IC | ||||||
| 11/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Not Applicable | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.42 | General |
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Cardiovascular | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $12.21 | General |
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.79 | General |
| 08/26/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 08/14/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.23 | General |
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Cardiovascular | ||||||
| 07/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiology | ||||||
| 07/17/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $112.05 | General |
| Category: Endovascular | ||||||
| 07/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 07/11/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 06/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Not Applicable | ||||||
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Not Applicable | ||||||
| 05/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Cardiology | ||||||
| 05/09/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.43 | General |
| 04/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 4,529 | 5,894 | $1.5M | $562,267 |
| 2022 | 44 | 3,706 | 4,769 | $1.0M | $381,994 |
| 2021 | 57 | 4,168 | 5,239 | $1.1M | $379,716 |
| 2020 | 54 | 4,618 | 6,809 | $1.2M | $422,051 |
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 78 | 78 | $227,641 | $88,493 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 781 | 932 | $201,312 | $85,046 | 42.2% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 97 | 194 | $154,812 | $60,694 | 39.2% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 18 | 18 | $96,156 | $37,693 | 39.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 219 | 223 | $92,248 | $31,380 | 34.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 164 | 165 | $66,660 | $23,417 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 151 | 164 | $48,052 | $21,526 | 44.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 101 | 103 | $66,332 | $21,319 | 32.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 118 | 472 | $53,336 | $19,717 | 37.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 38 | 43 | $55,470 | $19,438 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 133 | 135 | $55,823 | $18,232 | 32.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 108 | 158 | $33,654 | $14,720 | 43.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 931 | 1,166 | $39,644 | $11,965 | 30.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 32 | 32 | $29,984 | $10,056 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $29,392 | $10,021 | 34.1% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 16 | 16 | $47,376 | $9,869 | 20.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 172 | 174 | $26,191 | $9,038 | 34.5% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 28 | 30 | $21,930 | $7,240 | 33.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 136 | 136 | $19,312 | $7,051 | 36.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 64 | 107 | $12,441 | $5,744 | 46.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 90 | $13,410 | $5,634 | 42.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 32 | 64 | $15,104 | $5,595 | 37.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 77 | 213 | $13,419 | $4,459 | 33.2% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 45 | 45 | $9,360 | $3,292 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 50 | $7,350 | $3,205 | 43.6% |
About Dr. Mark Tulli, MD
Dr. Mark Tulli, MD is a Interventional Cardiology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265484257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Tulli, MD has received a total of $16,719 in payments from pharmaceutical and medical device companies, with $1,202 received in 2024. These payments were reported across 265 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($11,513).
As a Medicare-enrolled provider, Tulli has provided services to 17,021 Medicare beneficiaries, totaling 22,711 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Gainesville, FL
- Active Since 05/17/2006
- Last Updated 04/25/2013
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1265484257
Products in Payments
- Impella (Device) $1,305
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,275
- Mitra Clip system (Device) $1,229
- Xience V coronary stent system (Device) $1,200
- Repatha (Biological) $1,098
- Optis Coronary Imaging System (Device) $824.68
- CoreValve Evolut (Device) $807.05
- Omnilink Elite vascular stent system (Device) $700.00
- Perclose ProGlide suture mediated closure system (Device) $612.50
- 3F (Device) $582.75
- COREVALVE EVOLUT R (Device) $530.77
- XARELTO (Drug) $374.05
- Cardiac Monitoring Suite (Device) $287.08
- Corlanor (Drug) $268.80
- JARDIANCE (Drug) $260.51
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $228.24
- AVVIGO Guidance System (Device) $192.59
- Xience Sierra Coronary Stent (Device) $180.70
- FFRANGIO (Device) $149.63
- Vascular Lithotripsy (Device) $148.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Gainesville
Dr. Arthur Lee, Md, MD
Interventional Cardiology — Payments: $2.1M
Stephane Rinfret
Interventional Cardiology — Payments: $69,149
Dr. Christopher Caputo, Do, DO
Interventional Cardiology — Payments: $67,022
Zachary George, M.d, M.D
Interventional Cardiology — Payments: $60,629
Dr. Habib Samady, Md, MD
Interventional Cardiology — Payments: $43,588
Dr. Jeet Mehta, M.d, M.D
Interventional Cardiology — Payments: $25,361